Omalizumab (Xolair) is now available for NHS patients as an add-on treatment for severe, persistent allergic asthma in adults, adolescents and children, says NICE.
This follows additional analyses and the submission of a patient access scheme (PAS) by the manufacturer Novartis to the Department of Health which makes the treatment more cost-effective. In previous draft recommendations in November 2012, NICE was unable to recommend the treatment.
Brandon Medical is a UK manufacturer and designer of world-leading technology for operating theatres, critical care areas and primary care institutions. For over 70 years, Brandon Medical has provided healthcare professionals with reliable, high-quality and affordable medical equipment packages for operating theatres and critical care.
University of Warwick
8th - 9th August 2025
Manchester, Etihad Stadium
11th September 2025
Stansted Radisson Blu
23rd September 2025
Brighton Centre, UK
29th - 30th September 2025
Ramada Plaza, Wrexham
13th October 2025
EICC, Edinburgh
16th - 18th November 2025
